The Occlutech Atrial Flow Regulator (AFR) is an innovative cardiac implant which is designed to address the unmet medical needs of patients suffering from heart failure (HF) or pulmonary hypertension (PH) despite optimal medical therapy.
The Company has over 10 years of experience in the making and use of Nitinol-based cardiac implants and has developed the Occlutech AFR to provide an innovative, minimally invasive (non-sugical) treatment alternative to address the significant unmet medical needs in HF and PH patients.
The Occlutech AFR is a small implantable device made of Nitinol, a material used widely in implantable cardiac devices. The AFR device is implanted into the interatrial septum of the heart using routine, minimally invasive procedures.
Once implanted, the Occlutech AFR is intended to maintain a permanent interatrial communication with a predeterminied diameter (shunt). Depending on the indication (HF or PH), this shunt allows for the controlled flow of blood between the atria of the heart. The resulting decompression of the heart chambers is expected to lead to reduced symptoms and to improved execise tolerance and quality of life.